ArticleTherapeutic advances in medical oncology2025

Efficacy and safety of trastuzumab deruxtecan in Chinese patients with HER2-positive and HER2-low advanced breast cancer: a multicenter, observational, real-world study.

Die Sang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.